Free Newsletter
| Get the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Sign up for free today! |
Watchdogs circling DTC drug commercials
In what's becoming a daily update on the state of drug advertising, today the Los Angeles Times reviews the following:
- Congressional investigations of ads for the newly controversial med Vytorin, made by Merck and Schering-Plough, and the non-rowing, non-practicing doctor-slash-pitchman for Pfizer's Lipitor.
- A program that would have stepped up FDA oversight for such ads was scuttled last month for lack of funding.
- A Consumer Reports feature called AdWatch is stepping into the breach, reviewing info included--and neglected--of national ads. Its first subject: the restless-legs syndrome med Requip.
We were just as interested, though, in which drug websites are most popular with doctors, a list published by the Chicago Tribune. Here are the top five:
- Januvia
- Singulair
- Advair
- Chantix
- Adderal XR
The rest of the top 10, plus the 2006 list, are available at the link below. Hint: They include two of the biggest newsmakers of recent months.
- find the Manhattan Research ranking of websites
- read the report in the Los Angeles Times
- check out the website list in the Chicago Tribune
Related Articles:
Consumer group spoofs drug ads. Report
Final FDA bill lacks new DTC oversight. Report
Drug marketing costs double R&D. Report
FDA to study TV drug ad imagery. Report
Be the first to comment
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness


